Terazosin
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Synonyms / Brand Names: Terazosin HCl, Terazosin hydrochloride, Terazosina, Terazosine, Terazosinum, Trazosin HCl, Abbott 45975, Blavin, Flumarc, Fosfomic, Heitrin, Hytracin, Hytrin, Hytrinex, Itrin, Urodie, Vasocard, Vasomet, Vicard
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Dosing and Administration
Benign prostatic hyperplasia
- Initial dose: 1 mg at bedtime is the starting dose for all patients, and this dose should not be exceeded as an initial dose. Patients should be closely followed during initial administration in order to minimize the risk of severe hypotensive response.
Hypertension
- Initial dose: 1 mg at bedtime is the starting dose for all patients, and this dose should not be exceeded. This initial dosing regimen should be strictly observed to minimize the potential for severe hypotensive effects.
FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.
Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.
Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.
Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information
Trial Resources
Ongoing Trials, Trial Results
Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.
Media Resources
Slides, Video, Images, MP3, Podcasts, etc.
Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.
International Resources
en Español
FDA Package Insert Resources
Indications
Contraindications
Side Effects
Drug Interactions
Precautions
Overdose
Instructions for Administration
How Supplied
Pharmacokinetics and Molecular Data
FDA label
FDA on Terazosin
Return to top
Publication Resources
Most Recent Articles on Terazosin
Review Articles on Terazosin
Articles on Terazosin in N Eng J Med, Lancet, BMJ
WikiDoc State of the Art Review
Textbook Information on Terazosin
Return to top
Trial Resources
Ongoing Trials with Terazosin at Clinical Trials.gov
Trial Results with Terazosin
Return to top
Guidelines & Evidence Based Medicine Resources
US National Guidelines Clearinghouse on Terazosin
Cochrane Collaboration on Terazosin
Cost Effectiveness of Terazosin
Return to top
Media Resources
Powerpoint Slides on Terazosin
Images of Terazosin
Podcasts & MP3s on Terazosin
Videos on Terazosin
Return to top
Patient Resources
Patient Information from National Library of Medicine
Patient Resources on Terazosin
Discussion Groups on Terazosin
Patient Handouts on Terazosin
Blogs on Terazosin
Terazosin in the News
Terazosin in the Marketplace
Return to top
International Resources
Terazosin en Español
Return to top
The content of this page is taken from the FDA package insert for this drug and should not be edited.

